← Leaderboards
Dan Canaani
Tel Aviv University
$553,270
Attributed
$553,270
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $170.6K · FY2005–06$200K$150K$100K$50K$0
'05
'06
Funding mix
By agency
NIH$553,270 · 2
By mechanism
R01$337,270 · 1
R21$216,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Drug Discovery /Isolation”
- Nicholas Mark Valiante · Novartis Vaccines And Diagnostics, Inc.$4,680,300
- David G Kingston · Virginia Polytechnic Inst And St Univ$4,392,799
- William H Gerwick · Oregon State University$3,733,787
- John C Reed · University Of Texas Md Anderson Can Ctr$3,652,024
- Jeffery W Kelly · Scripps Research Institute$3,466,562
- Kathryn Frances Sykes · Eliance Biotechnology, Inc.$3,423,850
Research focus
Drug Discovery /IsolationTechnology /Technique DevelopmentBrca GeneCarboxylic Ester HydrolasesCarcinogenesisCell LineComplementary DnaEnzyme Induction /RepressionFlow CytometryFluorescence MicroscopyGene MutationGreen Fluorescent ProteinsIntermolecular InteractionLethal GenesMolecular GeneticsNeoplasm /Cancer GeneticsNeoplastic CellOvary NeoplasmsPhosphoester LigasePlasmidsProtein Structure FunctionWestern BlottingsBioassayAntineoplastics
Grant awards (4)
Synthetic lethality based assay for HTS drug discovery$166,630
R01 · FY2006 · CA · contact PI
Synthetic lethality based assay for HTS drug discovery$170,640
R01 · FY2005 · CA
Synthetic Lethal Screens in an Ovarian Cancer Model$108,000
R21 · FY2003 · CA
Synthetic Lethal Screens in an Ovarian Cancer Model$108,000
R21 · FY2002 · CA